XML 58 R43.htm IDEA: XBRL DOCUMENT v3.23.1
License and Collaboration Agreements (Details) - Apollomics, Inc.
$ in Millions
3 Months Ended
Mar. 31, 2020
USD ($)
Research and License Agreements  
Up-front payment received $ 9.0
Milestones based on achievement of certain clinical and regulatory events 75.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products 105.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1.0
Maximum  
Research and License Agreements  
Tiered percentage of annual net sales 15.00%